Rescue pulmonary vein isolation for hemodynamically unstable atrial fibrillation storm in a patient with an acute extensive myocardial infarction
© Morishima et al.; licensee BioMed Central Ltd. 2012
Received: 16 July 2012
Accepted: 22 November 2012
Published: 26 November 2012
New-onset atrial fibrillation in patients hospitalized for an acute myocardial infarction often leads to hemodynamic deterioration and has serious adverse prognostic implications; mortality is particularly high in patients with congestive heart failure and/or a reduced left ventricular ejection fraction. The mechanism of atrial fibrillation in the context of an acute myocardial infarction has not been well characterized and an effective treatment other than optimal medical therapy and mechanical hemodynamic support are expected.
A 71 year-old male with an acute myocardial infarction due to an occlusion of the left main coronary artery was treated with percutaneous coronary intervention. He had developed severe congestive heart failure with a left ventricular ejection fraction of 34%. The systemic circulation was maintained with an intraaortic balloon pump, continuous hemodiafiltration, and mechanical ventilation until atrial fibrillation occurred on day 3 which immediately led to cardiogenic shock. Because atrial fibrillation was refractory to intravenous amiodarone, beta-blockers, and a total of 15 electrical cardioversions, the patient underwent emergent radiofrequency catheter ablation on day 4. Soon after electrical cardioversion, ectopies from the right superior pulmonary vein triggered the initiation of atrial fibrillation. The right pulmonary veins were isolated during atrial fibrillation. Again, atrial fibrillation was electrically cardioverted, then, sinus rhythm was restored. Subsequently, the left pulmonary veins were isolated. The stabilization of the hemodynamics was successfully achieved with an increase in the blood pressure and urine volume. Hemodiafiltration and amiodarone were discontinued. The patient had been free from atrial fibrillation recurrence until he suddenly died due to ventricular fibrillation on day 9.
To the best of our knowledge, this is the first report of pulmonary vein isolation for a rescue purpose applied in a patient with hemodymically unstable atrial fibrillation complicated with an acute myocardial infarction. This case demonstrates that ectopic activity in the pulmonary veins may be responsible for triggering atrial fibrillation in the critical setting of an acute myocardial infarction and thus pulmonary vein isolation could be an effective therapeutic option.
KeywordsAtrial fibrillation Acute myocardial infarction Cardiogenic shock Catheter ablation Congestive heart failure Pulmonary vein isolation
New-onset atrial fibrillation (AF) in patients hospitalized for an acute myocardial infarction (AMI) often leads to hemodynamic deterioration and has serious adverse prognostic implications; mortality is particularly high in patients with congestive heart failure and/or a reduced left ventricular (LV) ejection fraction [1, 2]. The mechanism of AF in the context of an AMI has not been well characterized, and little has been published on the management strategies for AF in this setting.
To our knowledge, this is the first report of PV isolation (PVI) for a rescue purpose applied in a patient with hemodynamically unstable AF complicated with an AMI. The present case includes two major findings. First, AF may be triggered by ectopies from the PVs in the critical setting of AMI. Second, PVI may be effective for rhythm control and may thereby improve hemodynamic status.
AF, especially a new onset of AF, has been shown to be an independent predictor of mortality in patients with AMI [1, 2]. AF may cause adverse hemodynamic effects, such as loss of atrial contraction, rapid ventricular rates, loss of atrioventricular synchrony, and an irregular RR interval, leading to a decrease in cardiac output . Thus, when the patients are complicated with congestive heart failure, the development of AF should have greater adverse clinical significance than in cases without heart failure . Systemic circulation may collapse immediately. Even if it does not, insufficient coronary flow due to decreased cardiac output may lead not only to delaying the myocardial healing process but also to further myocardial damage, which starts a vicious cycle of hemodynamic deterioration. In this setting, AF could be a lethal arrhythmia. The present case is a typical example. The hemodynamics were barely maintained during sinus rhythm with the mechanical support of an IABP, but they immediately deteriorated due to the development of AF.
Despite the increasing evidence showing the prognostic significance of AF in patients with AMI, current therapeutic strategies in this setting seem to be limited to the management of hemodynamics, including IABP, mechanical ventilation, CHDF, and so forth. In addition, sedation with opioid analgesic drugs such as sufentanil might provide some cardioprotective / antiarrhythmic effects. These are the therapies generally given to AMI patients with congestive heart failure, but are not a specific treatment for AF. The rate control strategy may be accepted as an alternative to sinus rhythm restoration. However, attempts at rate control often fail when patients are on high levels of endogenous or exogenous catecholamines or are not able to tolerate the use of drugs including beta-blockers, digoxin, and calcium antagonists, because these agents have negative inotropic effects or may increase oxygen consumption. Furthermore, sinus rhythm should be necessary to maintain systemic circulation in patients with severe pump failure as shown in the present case. Amiodarone might be a drug that can be used in this setting . However, observational data recently suggested that an amiodarone-based rhythm control strategy in patients with AF after AMI complicated by heart failure or LV dysfunction is associated with excess early mortality when compared with the rate control strategy .
PVI has been accepted by consensus as the strategy of choice for the treatment of AF by catheter ablation . PVI exerts its beneficial effects by autonomic denervation of LA, by eliminating part of the arrhythmogenic substrate, and most importantly by eliminating AF triggers arising from PVs [6, 7]. However, it is not clear whether PVI also functions well in the setting of AMI where multiple precipitating factors may be involved in the development of AF. Those factors may include inflammation, acute hypoxia or hypokalaemia, endogenous or exogenous catecholamines, right ventricular infarction, and atrial ischemia . Hemodynamic impairment secondary to LV dysfunction such as a high pulmonary artery wedge pressure as well as right atrial pressure relate to the development of AF . The present case demonstrated that PVs play an important role as a source of AF triggers in this setting. PV-stretch due to elevated PV pressure might contribute to the triggering substrate . Although the patient died due to ventricular fibrillation, PVI successfully brought the patient back into sinus rhythm and clearly improved his hemodynamic status.
Based on this single case report, it is premature to draw conclusions that PVI could become a standard procedure to treat AF in the critical setting of an AMI. Since PVI is still a highly complex procedure, a careful assessment of benefit and risk must be considered for each patient.
Ectopic activity in the PVs may be responsible for triggering AF in the critical setting of an AMI. PVI in desperate cases, as a last resort, is feasible and could be an effective therapeutic option.
Written informed consent was obtained from the patient’s spouse for publication of this case report and accompanying images.
Acute myocardial infarction
Intraaortic balloon pump
Pulmonary vein isolation.
- Schmitt J, Duray G, Gersh BJ, Hohnloser SH: Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009, 30: 1038-1045. 10.1093/eurheartj/ehn579.View ArticlePubMedGoogle Scholar
- Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, Jouven X: Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011, 123: 1587-1593. 10.1161/CIRCULATIONAHA.110.986661.View ArticlePubMedPubMed CentralGoogle Scholar
- Clark DM, Plumb VJ, Epstein AE, Kay GN: Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997, 30: 1039-1045. 10.1016/S0735-1097(97)00254-4.View ArticlePubMedGoogle Scholar
- Ehrlich JR, Nattel S, Hohnloser SH: Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol. 2002, 13: 399-405. 10.1046/j.1540-8167.2002.00399.x.View ArticlePubMedGoogle Scholar
- Nilsson KR, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, Kober L, Granger CB, Lewis EF, McMurray JJ, Califf RM, Velazquez EJ: Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the valsartan in acute myocardial infarction (VALIANT) trial. Heart. 2010, 96: 838-842. 10.1136/hrt.2009.180182.View ArticlePubMedGoogle Scholar
- Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ, Davies DW, Dimarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D: 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm. 2012, 9: 632-696. 10.1016/j.hrthm.2011.12.016.View ArticlePubMedGoogle Scholar
- Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998, 339: 659-666. 10.1056/NEJM199809033391003.View ArticlePubMedGoogle Scholar
- Alasady M, Abhayaratna WP, Leong DP, Lim HS, Abed HS, Brooks AG, Mattchoss S, Roberts-Thomson KC, Worthley MI, Chew DP, Sanders P: Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm. 2011, 8: 955-960. 10.1016/j.hrthm.2011.02.016.View ArticlePubMedGoogle Scholar
- Sakata K, Kurihara H, Iwamori K, Maki A, Yoshino H, Yanagisawa A, Ishikawa K: Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol. 1997, 80: 1522-1527. 10.1016/S0002-9149(97)00746-7.View ArticlePubMedGoogle Scholar
- Kalifa J, Jalife J, Zaitsev AV, Bagwe S, Warren M, Moreno J, Berenfeld O, Nattel S: Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation. 2003, 108: 668-671. 10.1161/01.CIR.0000086979.39843.7B.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2261/12/110/prepub